BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 29, 2019
View Archived Issues
Outside of cell, intracellular enzyme is HER2 inhibitor
Read More
Relaxation Rx for hypertrophic cardiomyopathy
Read More
Neurogenic pain receptor identified
Read More
Bacterial virulence factor contributes to brain damage in AD
Read More
New sphingosine 1-phosphate receptor antagonists reported by Galapagos
Read More
Sanofi patents new antimalarials
Read More
Inflazome describes NLRP3 inflammasome inhibitors
Read More
Peking University discovers STAT3 inhibitors
Read More
Selection Bioscience patents indoleamine 2,3-dioxygenase 1 inhibitors
Read More
Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine describe RORC agonists/inverse agonists
Read More
FDA approves I-Mab's IND to initiate phase I/Ib study of TJC-4
Read More
First volunteer dosed in phase I study of HBV therapy DCR-HBVS
Read More
LJ-2618, a new selenonucleoside, inhibits prostate cancer tumor growth in vivo
Read More
GB-1211 begins first-in-human trial in healthy volunteers and subjects with NASH and liver fibrosis
Read More
Enyo Pharma initiates phase IIa study of EYP-001a in NASH
Read More
Horizon Discovery partners with Rutgers University on base editing platform
Read More
MedImmune studies MEDI-7247 in phase I/Ib trial for advanced or metastatic solid tumors
Read More
Rocket studies RP-L201 in pediatric patients with severe leukocyte adhesion deficiency-I
Read More
Phase I data presented for mAb114 monoclonal antibody for treating Ebola virus
Read More
Small molecule targets the most common genetic cause of ALS
Read More
Topline results from second phase III study of tanezumab in OA pain
Read More
Triphase enters strategic collaboration with Celgene for TRPH-395
Read More
Chinese IND clearance for CARsgen's GPC3-CAR-T cells for solid tumors
Read More
